Previously unreported adverse reaction to encainide.
We describe a patient with recurrent atrial fibrillation who suffered a previously unreported adverse reaction to encainide therapy manifested by fever, chills, diaphoresis and myalgia. The patient had a similar response upon rechallenging with encainide, which resolved on discontinuation of therapy.
Goli-Bijanki
R
R
Division of Cardiology and Allergy-Immunology, Creighton University School of Medicine, Omaha, NE.
Nair
C K
CK
Nair
N
N
Sketch
M H
MH
D000368:Aged; D000813:Anilides / Q000009:adverse effects* / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy; D016700:Encainide; D005334:Fever / Q000139:chemically induced; D006801:Humans; D008297:Male; D009135:Muscular Diseases / Q000139:chemically induced; D012768:Shivering; D013546:Sweating
D000813:Anilides; D000889:Anti-Arrhythmia Agents; D016700:Encainide